Due to a national shortage of blood collection tubes, you may experience upwards of a 2-hour delay in processing time for certain tests. Someone from our team will advise you if your scheduled lab test is affected by this delay. We thank you in advance for your patience.

Clinical Trials & Research

KEAP1/NRF2 NSCLC

CX-839-014 "KEAPSAKE": A Phase 2, Randomized, Multicenter, Double-blind, Study of the Glutaminase Inhibitor Telaglenastat with Pembrolizumab and Chemotherapy versus Placebo with Pembrolizumab and Chemotherapy in First-line Metastatic KEAP1/NRF2-mutated Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Disease Types: Lung (Non Small Cell),&nbs

Available at: {clinical_trial_location backspace="7"}KEAP1/NRF2 NSCLC, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}

{clinical_trial_description}